The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain

Biochemical Pharmacology

Volumn 82, Issue 3, 2011, Pages 287-294

  Zhang, Yu ^a   Dong, Jibin ^b   Zhu, Xingang ^a   Wang, Weirong ^a   Yang, Qing ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Brain; Drug transporters; ERM proteins; Sphingomyelin synthase 2

Indexed keywords

BETA ACTIN; CARRIER PROTEIN; EZRIN; GLYCOPROTEIN P; MESSENGER RNA; MOESIN; MULTIDRUG RESISTANCE PROTEIN 1; RADIXIN; SPHINGOMYELIN; SPHINGOMYELIN SYNTHASE 2; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; DOWN REGULATION; ENZYME DEFICIENCY; GENE EXPRESSION PROFILING; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ANIMALS; BRAIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; P-GLYCOPROTEIN; TRANSCRIPTION FACTORS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 80955180545     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.04.009     Document Type: Article

References (31)

1. R.B. Kim Transporters and drug discovery: why, when, and how Mol Pharm 3 2006 26 32 (Pubitemid 43331748)
2. N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of drug transporter studies on drug discovery and development Pharmacol Rev 55 2003 425 461 (Pubitemid 37013212)
3. D.S. Miller Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier Trends Pharmacol Sci 31 2010 246 254
4. B. Bauer, A.M. Hartz, and D.S. Miller Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier Mol Pharmacol 71 2007 667 675 (Pubitemid 46294078)
5. A.M. Hartz, B. Bauer, M.L. Block, J.S. Hong, and D.S. Miller Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier FASEB J 22 2008 2723 2733
6. L. Fouassier, M. Beaussier, E. Schiffer, C. Rey, V. Barbu, and M. Mergey Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes Am J Physiol Gastrointest Liver Physiol 293 2007 G25 G35
7. M.P. McRae, K.L.R. Brouwer, and A.D.M. Kashuba Cytokine regulation of P-glycoprotein Drug Metab Rev 35 2003 19 33 (Pubitemid 36249784)
8. E.A. Ho, and M. Piquette-Miller Regulation of multidrug resistance by pro-inflammatory cytokines Curr Cancer Drug Targets 6 2006 295 311 (Pubitemid 43961865)
9. T. Tchenio, M. Havard, L.A. Martinez, and F. Dautry Heat shock-independent induction of multidrug resistance by heat shock factor 1 Mol Cell Biol 26 5 2006 80 591
10. R. Callaghan, G. Berridge, D.R. Ferry, and C.F. Higgins The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface Biochim Biophys Acta 1328 1997 109 124 (Pubitemid 27376440)
11. R.N. Kolesnick Sphingomyelin and derivatives as cellular signals Prog Lipid Res 30 1991 1 38 (Pubitemid 121002989)
12. K. Huitema, J. van den Dikkenberg, J.F. Brouwers, and J.C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J 23 2004 33 44 (Pubitemid 38165745)
13. Z. Li, T.K. Hailemariam, H. Zhou, Y. Li, D.C. Duckworth, and D.A. Peake Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization Biochim Biophys Acta 1771 2007 1186 1194 (Pubitemid 47404966)
14. J. Liu, C. Huan, M. Chakraborty, H. Zhang, D. Lu, and M.S. Kuo Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice Circ Res 105 2009 295 303
15. H. Sakai, Y. Tanaka, M. Tanaka, N. Ban, K. Yamada, and Y. Matsumura ABCA2 deficiency results in abnormal sphingolipid metabolism in mouse brain J Biol Chem 282 2007 19692 19699 (Pubitemid 47100090)
16. F. Luciani, A. Molinari, F. Lozupone, A. Calcabrini, L. Lugini, and A. Stringaro P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin Blood 99 2002 641 648 (Pubitemid 34533103)
17. H. Takeshita, K. Kusuzaki, T. Ashihara, M.C. Gebhardt, H.J. Mankin, and Y. Hirasawa Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance Cancer Lett. 126 1998 75 81 (Pubitemid 28142974)
18. S. Kikuchi, M. Hata, K. Fukumoto, Y. Yamane, T. Matsui, and A. Tamura Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes Nat Genet 31 2002 320 325
19. Q. Yang, R. Onuki, C. Nakai, and Y. Sugiyama Ezrin and radixin both regulate the apical membrane localization of ABCC2 (MRP2) in human intestinal epithelial Caco-2 cells Exp Cell Res 313 2007 3517 3525 (Pubitemid 47404555)
20. T.K. Hailemariam, C. Huan, J. Liu, Z. Li, C. Roman, and M. Kalbfeisch Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation Arterioscler Thromb Vasc Biol 28 2008 1519 1526
21. A. Meng, C. Luberto, P. Meier, A. Bai, X. Yang, and Y.A. Hannun Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells Exp Cell Res 292 2004 385 392 (Pubitemid 38018853)
22. M.R. Hojjati, and X.C. Jiang Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine J Lipid Res 47 2006 673 676 (Pubitemid 43345608)
23. J. Dong, J. Liu, B. Lou, Z. Li, X. Ye, and M. Wu Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice J Lipid Res 47 2006 1307 1314 (Pubitemid 43830723)
24. G. Patwardhan, V. Gupta, J. Huang, X. Gu, and Y.Y. Liu Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy Biochem Pharmacol 80 2010 72 79
25. P. Borst, R. Evers, M. Kool, J. Wijnholds, and M. Wada The multidrug resistance protein family Biochim Biophys Acta 1461 1999 347 357
26. M. Kuwano, S. Toh, T. Uchiumi, H. Takano, K. Kohno, and M. Wada Multidrug resistance-associated protein subfamily transporters and drug resistance Anticancer Drug Res 14 1999 123 131 (Pubitemid 29292309)
27. K. Klappe, I. Hummel, D. Hoekstra, and J.W. Kok Lipid dependence of ABC transporter localization and function Chem Phys Lipids 161 2009 57 64
28. Y. Lavie, G. Fiucci, and M. Liscovitch Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells J Biol Chem 273 1998 32380 32383 (Pubitemid 28557607)
29. S. Barakat, L. Gayet, G. Dayan, S. Labialle, A. Lazar, and V. Oleinikov Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated Pgp ATPase activities: evidence from atomic force microscopy and biochemical analysis Biochem J 388 2005 563 571 (Pubitemid 40839934)
30. D.B. Short, K.W. Trotter, D. Reczek, S.M. Kreda, A. Bretscher, and R.C. Boucher An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton J Biol Chem 273 1998 19797 19801 (Pubitemid 28367041)
31. H. Kojima, A.T. Nies1, J. König, W. Hagmann, H. Spring, and M. Uemura Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis J Hepatol 39 2003 693 702 (Pubitemid 37372176)